Evidence map›Paper›PMID 35777394›Full record

ArticleInternational journal of radiation oncology, biology, physics2022

Adaptive Phase 1 Design in Radiation Therapy Trials.

Nolan A Wages, Thomas M Braun, Daniel P Normolle, Matthew J Schipper

Abstract readClinical Trial, Phase I
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nolan A WagesDivision of Translational Research & Applied Statistics, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia. Electronic address: nwages@virginia.edu.
Thomas M BraunDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Daniel P NormolleDepartment of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
Matthew J SchipperDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Dose finding designs for late-onset toxicitiesR01CA247932 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI WAGES, NOLAN · 2021 to 2023
$1.0M
NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA247932
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Research DesignHumansSample Size

Identifiers

PMID35777394
PMCPMC9260906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.